Neoadjuvant nivolumab + T-VEC combination therapy for resectable early stage or metastatic (IIIB-IVM1a) melanoma with injectable disease: study protocol of the NIVEC trial
Author(s):
Rohaan, M.W. (0000-0003-1470-9427); Stahlie, E.H.A.; Franke, V.; Zijlker, L.P.; Wilgenhof, S.; Noort, V. van der; Akkooi, A.C.J. van; Haanen, J.B.A.G.
